Apimeds Pharmaceuticals US, Inc. (APUS) Stock Price, Quote & AI Analysis
Live APUS stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Apimeds Pharmaceuticals US, Inc..
TradeVae provides AI-driven analysis and real-time market intelligence for Apimeds Pharmaceuticals US, Inc. (APUS), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Apimeds Pharmaceuticals US, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Apimeds Pharmaceuticals US, Inc. Overview
Company information
Company Overview
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Apimeds Pharmaceuticals US, Inc. Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...